Subscribe
Close
  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Renew

Canada-Based TSO3 Inc Plans United States Facility In Myrtle Beach, South Carolina

07/06/2015
TSO3 Inc., a Canada-based innovator in sterilization technology for medical devices in healthcare settings, announced the formation of a wholly owned U.S. subsidiary, TSO3 Corporation in Myrtle Beach, South Carolina.

The Company leased an approximately 6,000 square foot facility in Myrtle Beach. The location will house US customer service, clinical education and also act as a U.S. warehouse and service depot. The new location is expected to open in August of this year in time to meet US customer requirements. According to the firm, the new entity is being created to meet the demands of U.S. customers for product, service and education.

"During the second quarter the Company focused a great deal of its energies in developing a formal commercialization process for the STERIZONE Sterilization System." said R.M. (Ric) Rumble, President/CEO. "Alone and together with our sales and service partner Getinge Infection Control, the Company has made great strides, which we believe will result in securing contract positions with the largest and leading Group Purchasing Organizations and Integrated Delivery Networks.

“In addition, TSO3is ushering "scores" of quotes through their individual processes, many of which the Company expects to successfully close. As a result of these efforts, it became clear that it was time to execute our plans to open a United States location focused on the education and ongoing service requirements of the U.S. customers." explained Mr. Rumble.

"While the foundation and technical expertise of the Company is and will remain in Quebec City, establishing a presence in the U.S., which represents 40% of the worldwide market, will allow us to more effectively reach out to and service this high opportunity market", Rumble added.

Exclusive Research